Breaking New Ground

A proper initial set-up is vital when establishing a new laboratory for industrial, commercial, or clinical manufacturing applications.

Written byCytiva
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Laboratories for industrial, commercial, or clinical manufacturing applications have different objectives than typical academic research laboratories, with workflow efficiency and regulatory compliance essential for smooth operations. Researchers need to carefully balance workflow design and instrumentation needs alongside scaling and expansion plans when setting up their manufacturing operations. A proper initial set-up establishes a firm foundation, and offers much more cost-effectiveness and efficiency compared to constantly re-tooling or tinkering with a process after everything has been put into place.

Starting with the Workflow

Workflow requirements are the primary driving force affecting how a new industrial or commercial laboratory is set up. Biological products, especially ones designed for clinical applications, must adhere to regulatory requirements in terms of quality, consistency, efficacy, and safety. Current Good Manufacturing Practices (cGMP) dictate that the best way to assure product compliance is to implement a workflow that follows cGMP at every step.

Spatial organization can be a big part of becoming cGMP compliant: Will there be enough space for the specific instruments required? Will environmental controls need to be implemented—for the whole facility or just a portion of it? Are there specific conditions that need to be met when transferring the product from one stage of the workflow to the next? Moreover, what is enough for today may not be sufficient for tomorrow. Researchers should strive to build flexibility into their workflows and their facilities so that they can potentially scale-up without rebuilding their workflow or moving shop.

Supporting Enterprising Endeavors

All of this creates a delicate balancing act. Worrying too much about the future can introduce excessive risk (i.e. spending too much capital on an overly large facility) before a venture has established a firm foothold. However, not paying attention to the future can create cost inefficiencies down the line. Fortunately, researchers moving into the commercial or clinical sector do have resources at their disposal. Cytiva’s Enterprise Solutions, for example, packages technology, facilities, and services together to create an end-to-end platform aiming to address the complexities of biomanufacturing.

See “Moving into Biological Manufacturing

The FlexFactoryTM platform is a key part of Enterprise Solutions, and is a customizable manufacturing platform for supporting scale-up or scale-out processes. Together with Cytiva experts in process design, researchers can design and configure single-use or hybrid manufacturing platforms for their unique bioprocessing or manufacturing needs that can be up and running in 12 months. FlexFactory platforms can be installed in new or existing facilities, and are designed with regulatory compliance and cGMP in mind. FlexFactory also heavily implements automation for improved efficiency and consistency, and data from each instrument is centralized on a single workstation for real-time monitoring and control.

Cytiva Enterprise Solutions also provide options for researchers without existing facilities. KUBioTM modular facilities reduce costs and project timelines by using prefabricated modules that can be constructed in parallel. A KUBio facility can be ready in as little as 18 months, and the modular nature of KUBio solutions also facilitates easier expansion down the line, especially because FlexFactory platforms are included as a fundamental part of each KUBio. This altogether minimizes researcher risk by not forcing them to expand too fast too quickly, while still retaining the option to expand at a more appropriate time in the future without having to abandon existing workflows and facilities.

As an end-to-end platform Enterprise Solutions further offers comprehensive services and support options for researchers moving into biomanufacturing. This comprehensive offering includes: training and education, process development services, bridge manufacturing, and flexible maintenance support. The initial foray into the commercial sector can be daunting, but awareness of major pitfalls, combined with a well-established expert support network can help smooth the road ahead.

  1. B. Goldstein, P. Avasthi, “Guide to setting up and managing a lab at a research-intensive institution,” BMC Proc, 15:8, 2021.
  2. C.L.L. Dahlberg et al., “Building a laboratory at a Primarily Undergraduate Institution (PUI),” BMC Proc, 15:2, 2021.
Cytiva logo
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform